ATHA Congressional Stock Trades
Athira Pharma, Inc. (ATHA)
Last disclosed trade Dec 12
Every disclosed trade in ATHA by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.
Sample · the intelligence layer
Christopher L. Jacobs · Bought $ATHA · Dec 12 · $1K–$15K
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow $ATHA
Get notified when any member of Congress trades $ATHA. Free, no card, no spam.
The record on $ATHA
Coldpine has parsed 1 disclosed trade in $ATHA by 1 member of Congress, drawn from 1 periodic transaction report dated Dec 12, 2022. It came from the House, filed by a Democrat.
The one trade with a known filing lag was reported 39 days after the trade date, inside the 45-day window the STOCK Act sets: a $ATHA purchase by Christopher L. Jacobs dated Dec 12, 2022, disclosed Jan 20, 2023. How late filing is measured across all of Congress is in the late-filers study.
Members who trade ATHA
Recent disclosed trades in ATHA
| Date | Member | Type | Amount |
|---|---|---|---|
| Dec 12 | Christopher L. Jacobs(NY) | buy | $1K–$15K |
Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →